AI-assisted telehealth platform for managing chronic diseases
An Accessible and Inclusive Artificial Intelligence Assisted Chronic Disease Self-Management Telehealth Platform: a Pilot Study
This study is testing a new online program that uses AI to help adults with mobility issues and chronic diseases make healthier lifestyle changes with the support of coaching and rewards.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 212 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Trial ID | NCT05481593 on ClinicalTrials.gov |
What this trial studies
This study aims to pilot test an AI-assisted, individualized, family-focused lifestyle modification intervention designed to improve health-related quality of life for adults with impaired mobility and chronic medical conditions. Participants will be randomly assigned to one of four groups, each receiving different combinations of scheduled coaching calls and rewards, either gamified or independent. The intervention will last for six months, focusing on enhancing self-management of chronic diseases through technology. The study seeks to evaluate the effectiveness of these approaches in promoting healthier lifestyles.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with heart disease, chronic lung disease, or Type 2 diabetes, who also have a permanent physical disability.
Not a fit: Patients with severe cognitive impairment, untreated severe depression, or those currently enrolled in another structured intervention may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the quality of life for patients with chronic conditions and mobility impairments.
How similar studies have performed: Other studies have shown promise in using technology and gamification for chronic disease management, indicating potential success for this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Diagnosis of heart disease, chronic lung disease, or Type 2 diabetes * Living with a permanent physical disability (i.e., spina bifida, multiple sclerosis, stroke,) * Have the ability to converse in and read English * Availability of a smartphone or computer Exclusion Criteria: * Current enrollment in any structured intervention * Severe cognitive impairment * Severe untreated depression in the past 6 months * Major cardiac event in the past 12 months * Uncontrolled blood pressure * Resting tachycardia * Renal failure * Severe peripheral neuropathy * Active treatment for cancer in the past 12 months * Having both visual and hearing impairments (either of them is fine)
Where this trial is running
Birmingham, Alabama
- University of Alabama at Birmingham — Birmingham, Alabama, United States (Recruiting)
Study contacts
- Study coordinator: Eric J Evans, PhD
- Email: evansej@uab.edu
- Phone: 205-934-7189
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.